The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report.

Choi, Yu Jeong; Kook, Hye Won; Lee, Seung-Tae; Song, Jaewoo; Choi, Jong Rak; Cheong, June-Won; Shin, Saeam

Choi, Yu Jeong; Kook, Hye Won; Lee, Seung-Tae; Song, Jaewoo; Choi, Jong Rak; Cheong, June-Won; Shin, Saeam.

Afiliação

Choi YJ; Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Kook HW; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Lee ST; Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Song J; Dxome Co. Ltd, Seongnam, Korea.
Choi JR; Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Cheong JW; Department of Laboratory Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
Shin S; Dxome Co. Ltd, Seongnam, Korea.

Leuk Lymphoma ; : 1-4, 2024 Jul 29.

Article em En | MEDLINE | ID: mdl-39072445

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google